331 related articles for article (PubMed ID: 8791964)
1. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.
Hartmann M; Theiss U; Huber R; Lühmann R; Bliesath H; Wurst W; Lücker PW
Aliment Pharmacol Ther; 1996 Jun; 10(3):359-66. PubMed ID: 8791964
[TBL] [Abstract][Full Text] [Related]
2. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administration.
Ehrlich A; Lücker PW; Wiedemann A; Sander P; Huber R; Mascher H
Methods Find Exp Clin Pharmacol; 1999; 21(1):47-51. PubMed ID: 10222447
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg.
Florent C; Forestier S
Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):195-200. PubMed ID: 9058634
[TBL] [Abstract][Full Text] [Related]
5. A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH.
Täubel JJ; Sharma VK; Chiu YL; Lukasik NL; Pilmer BL; Pan WJ
Aliment Pharmacol Ther; 2001 Nov; 15(11):1807-17. PubMed ID: 11683695
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.
Tutuian R; Katz PO; Bochenek W; Castell DO
Aliment Pharmacol Ther; 2002 Apr; 16(4):829-36. PubMed ID: 11929403
[TBL] [Abstract][Full Text] [Related]
7. Acid suppression in healthy subjects following lansoprazole or pantoprazole.
Huang JQ; Goldwater DR; Thomson AB; Appelman SA; Sridhar S; James CF; Chiu YL; Pilmer BL; Keith RG; Hunt RH
Aliment Pharmacol Ther; 2002 Mar; 16(3):425-33. PubMed ID: 11876695
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects.
Geus WP; Mathôt RA; Mulder PG; Lamers CB
Aliment Pharmacol Ther; 2000 Aug; 14(8):1057-64. PubMed ID: 10930900
[TBL] [Abstract][Full Text] [Related]
10. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole.
Hartmann M; Ehrlich A; Fuder H; Lühmann R; Emeklibas S; Timmer W; Wurst W; Lücker PW
Aliment Pharmacol Ther; 1998 Oct; 12(10):1027-32. PubMed ID: 9798809
[TBL] [Abstract][Full Text] [Related]
11. Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.
Lin HJ; Lo WC; Cheng YC; Perng CL
Clin Ther; 2006 Sep; 28(9):1303-7. PubMed ID: 17062303
[TBL] [Abstract][Full Text] [Related]
12. Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors.
Pantoflickova D; Dorta G; Ravic M; Jornod P; Blum AL
Aliment Pharmacol Ther; 2003 Jun; 17(12):1507-14. PubMed ID: 12823153
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole.
Andersson T; Holmberg J; Röhss K; Walan A
Br J Clin Pharmacol; 1998 Apr; 45(4):369-75. PubMed ID: 9578184
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers.
Calabresi L; Pazzucconi F; Ferrara S; Di Paolo A; Tacca MD; Sirtori C
Pharmacol Res; 2004 May; 49(5):493-9. PubMed ID: 14998561
[TBL] [Abstract][Full Text] [Related]
15. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.
Londong W
Aliment Pharmacol Ther; 1994; 8 Suppl 1():39-46. PubMed ID: 8180293
[TBL] [Abstract][Full Text] [Related]
16. Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH.
Müssig S; Witzel L; Lühmann R; Schneider A
Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):599-602. PubMed ID: 9222733
[TBL] [Abstract][Full Text] [Related]
17. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
[TBL] [Abstract][Full Text] [Related]
18. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
Röhss K; Lind T; Wilder-Smith C
Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
[TBL] [Abstract][Full Text] [Related]
19. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Burkhardt F
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
[TBL] [Abstract][Full Text] [Related]
20. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Ramdani A; Mignon M; Samoyeau R
Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]